WASHINGTON (Reuters) - The new AIDS drug Prezista performed very well in halting the onslaught of the human immunodeficiency virus in people with advanced infection, a study published on Wednesday showed.The success of the drug, made by the Johnson & Johnson unit Tibotec Pharmaceuticals Ltd., comes at a time of acute need for new AIDS therapies because many existing drugs are failing as HIV mutates to thwart them.>>> Discuss This Story
